Frederick L. Glick

This profile gathers the share dealings of Frederick L. Glick across 2 companies, led by Sonnet BioTherapeutics Holdings, Inc. and Amergent Hospitality Group Inc. In total, 5 filings cover trades dated from 30 November 2018 to 2 August 2021.

On the market, this insider has only ever bought: 4 purchases, €44k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant. Since January 2021: 1 purchase and no sales on the market.

In size, the median ticket on the buying side is €11k. Of 4 purchases, 3 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

Most recently, on 5 August 2021, the filings show an open-market purchase worth €20k in Amergent Hospitality Group Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.